The burden of disease of Herpes Zoster in Tuscany

References

• Gabutti G, Serenelli C, Sarno O, Marconi S, Corazza M, Virgili A. Epidemiologic features of patients affected by herpes zoster: database analysis of the Ferrara University Dermatology Unit, Italy. Med Mal Infect 2010; 40:268 - 72; http://dx.doi.org/10.1016/j.medmal.2009.09.005; PMID: 19836913
   PubMed Web of Science ®Google Scholar
• Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48:Suppl 1 S2 - 7; http://dx.doi.org/10.1016/S1386-6532(10)70002-0; PMID: 20510263
   PubMed Web of Science ®Google Scholar
• Cherubini A, Gasperini B. Prevenzione delle infezioni da Herpes Zoster nella popolazione anziana e gestione della nevralgia post-erpetica. [Prevention of Herpes Zoster infections in the elderly and management of post-herpetic neuralgia] G Gerontol 2008; 56:146 - 53
   Google Scholar
• Yoshikawa TT, Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32:1481 - 6; http://dx.doi.org/10.1086/320169; PMID: 11317250
   PubMed Web of Science ®Google Scholar
• Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137:38 - 47; http://dx.doi.org/10.1017/S0950268808000678; PMID: 18466661
   PubMed Web of Science ®Google Scholar
• Gabutti G, Serenelli C, Cavallaro A, Ragni P. Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms. Int J Environ Res Public Health 2009; 6:2344 - 53; http://dx.doi.org/10.3390/ijerph6092344; PMID: 19826547
   PubMed Web of Science ®Google Scholar
• Gagliardi AM, Gomes Silva BN, Torloni MR, Soares BG. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev 2012; 10:CD008858; PMID: 23076951
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos L, De Serres G. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001; 127:305 - 14; http://dx.doi.org/10.1017/S0950268801005921; PMID: 11693508
   PubMed Web of Science ®Google Scholar
• Schmader K. Herpes Zoster. In: Yoshikawa T, Norman D, eds. Infectious Disease in the Aging - A Clinical Handbook. 2nd Edition: Humana Press, 2009:229-42.
   Google Scholar
• Bowsher D. Factors influencing the features of postherpetic neuralgia and outcome when treated with tricyclics. Eur J Pain 2003; 7:1 - 7; http://dx.doi.org/10.1016/S1090-3801(02)00060-5; PMID: 12527312
   PubMed Web of Science ®Google Scholar
• Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62:1545 - 51; http://dx.doi.org/10.1212/01.WNL.0000123261.00004.29; PMID: 15136679
   PubMed Web of Science ®Google Scholar
• Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004; 39:342 - 8; http://dx.doi.org/10.1086/421942; PMID: 15307000
   PubMed Web of Science ®Google Scholar
• Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 2014; 58:1497 - 503; http://dx.doi.org/10.1093/cid/ciu098; PMID: 24700656
   PubMed Web of Science ®Google Scholar
• Wilson DD. Herpes zoster: A rash demanding careful evaluation. Nurse Pract 2014; 39:30 - 6, quiz 36-7; http://dx.doi.org/10.1097/01.NPR.0000445781.37062.16; PMID: 24681697
   PubMedGoogle Scholar
• Pinchinat S, Cebrián-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis 2013; 13:170; http://dx.doi.org/10.1186/1471-2334-13-170; PMID: 23574765
   PubMed Web of Science ®Google Scholar
• Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010; 10:230; http://dx.doi.org/10.1186/1471-2334-10-230; PMID: 20682044
   PubMed Web of Science ®Google Scholar
• Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 2001; 19:3076 - 90; http://dx.doi.org/10.1016/S0264-410X(01)00044-5; PMID: 11312002
   PubMed Web of Science ®Google Scholar
• Gould D. Varicella zoster virus: chickenpox and shingles. Nurs Stand 2014; 28:52 - 8, quiz 60; http://dx.doi.org/10.7748/ns2014.04.28.33.52.e8249; PMID: 24734838
   PubMedGoogle Scholar
• Schmader KE, Levin MJ, Gnann JW Jr., McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su S-C, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54:922 - 8; http://dx.doi.org/10.1093/cid/cir970; PMID: 22291101
   PubMed Web of Science ®Google Scholar
• Oxman MN. Vaccination to prevent herpes zoster and postherpetic neuralgia. Hum Vaccin 2007; 3:64 - 8; http://dx.doi.org/10.4161/hv.3.2.3746; PMID: 17299270
   PubMed Web of Science ®Google Scholar
• Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine 2014; 32:1645 - 53; http://dx.doi.org/10.1016/j.vaccine.2014.01.058; PMID: 24534737
   PubMed Web of Science ®Google Scholar
• http://www.sigg.it/public/doc/congresso/58/29-11-2013/SALA-500/12.30%20-%2013.00/174-Stefania%20Maggi/Stefania-Maggi.pdf.
   Google Scholar
• Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25:7866 - 72; http://dx.doi.org/10.1016/j.vaccine.2007.07.036; PMID: 17919788
   PubMed Web of Science ®Google Scholar
• Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res 2013; 13:359; http://dx.doi.org/10.1186/1472-6963-13-359; PMID: 24070414
   PubMed Web of Science ®Google Scholar
• Sanford M, Keating GM. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Drugs Aging 2010; 27:159 - 76; http://dx.doi.org/10.2165/10489140-000000000-00000; PMID: 20104941
   PubMed Web of Science ®Google Scholar
• de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands. Vaccine 2013; 31:1276 - 83; http://dx.doi.org/10.1016/j.vaccine.2012.12.067; PMID: 23306360
   PubMed Web of Science ®Google Scholar
• Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine 2014; 32:1645 - 53; http://dx.doi.org/10.1016/j.vaccine.2014.01.058; PMID: 24534737
   PubMed Web of Science ®Google Scholar
• Szucs TD, Pfeil AM. A systematic review of the cost effectiveness of herpes zoster vaccination. Pharmacoeconomics 2013; 31:125 - 36; http://dx.doi.org/10.1007/s40273-012-0020-7; PMID: 23335045
   PubMed Web of Science ®Google Scholar